nat rev cancernature cancer impact factor

  • Redeployment of Myc and E2f1-3 drives Rb-deficient cell

    Nat Rev Mol Cell Biol. 2015 Sep16(9) 516-7. Robust mechanisms to control cell proliferation have evolved to maintain the integrity of organ architecture. Here, we investigated how two critical proliferative pathways, Myc and E2f, are integrated to control cell cycles in normal and Rb-deficient cells using a murine intestinal model.

  • Cancer and Radiation Therapy Current Advances and Future

     · Cancer and Radiation Therapy Current Advances and Future Directions. 1. Department of Radiation Oncology, National Cancer Centre, 11- Hospital Drive, Singapore, Singapore 2. Division of Cellular and Molecular Research, National Cancer Centre, 11- Hospital Drive, Singapore, Singapore. This is an open access article distributed

  • Cancer nanotechnology application of nanotechnology in

     · Cancer is a major cause of mortality more than ten million people are diagnosed with the disease annually. Cancer is known to develop via a multistep carcinogenesis process entailing numerous cellular physiological systems such as cell signaling and apoptosis, making it a highly incomprehensible and complex disease 1, 2.Initially, cancers start as localized diseases, but they are prone to

  • Cancer and the microbiota Science

     · A host’s microbiota may increase, diminish, or have no effect at all on cancer susceptibility. Assigning causal roles in cancer to specific microbes and microbiotas, unraveling host-microbiota interactions with environmental factors in carcinogenesis, and exploiting such knowledge for cancer diagnosis and treatment are areas of intensive interest. This Review considers how microbes and the

  • Nature Reviews Immunology Impact Factor IF

    Bioxbio Journal Impact* IF Total Articles Total Cites 2019/.358 52 42168 .019 52 41499 .982 54 39215 .932 54 34948 .416 58 31545 .985 60 28938 .836 65 27024 .129 65 24831 2011

  • JNCI Journal of the National Cancer Institute Oxford

    Impact Factor. 13.506. 5 year Impact Factor. 13.893. Editor-in-Chief. Dr. Patricia Ganz. Immunotherapy Collection. The editors of JNCI and JNCI Cancer Spectrum have curated a selection of key immunotherapy papers published by both journals in recent years. All articles are open access or have been made freely available for a limited time.

  • Journal Impact FactorsRoyal Society of Chemistry

    2 days ago · Journal Impact Factors 2019. As a not-for-profit, society publisher, we ensure the quality and wide dissemination of chemical knowledgethrough robust review, global reach and the publication of both fundamental and applied research. Our organisation is made of active scientistsRoyal Society of Chemistry members, authors, reviewers

  • Nature reviews. Cancer (NAT REV CANCER)ResearchGate

    Deeb KK, Trump DL, Johnson CSVitamin D signalling pathways in cancer Potential for anticancer therapeutics. Nat Rev Cancer 7 , doi 10.1038/nrc.2196

  • Counting the invisible costs of covid-19 the cancer

     · Cancer, COVID-19 and the precautionary principle prioritizing treatment during a global pandemic. Nat Rev Clin Oncol. 202017(5) 268-70. Lee LY, Cazier JB, Angelis V, Arnold R, Bisht V, Campton NA, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments a prospective cohort study.

  • Biorepositories for cancer research in developing

     · Well-documented biorepositories are essential for cancer research. Currently, major biobanks are located in the developed world, which represents the minority global population however, countries with low-resource settings contribute more than 50% of the global cancer burden. Therefore, there is an urgent need to establish next generation biorepositories in developing countries.

  • Global Cancer ObservatoryCancer Stories

    About . The Global Cancer Observatory (GCO) is an interactive web-based platform presenting global cancer statistics to inform cancer control and cancer research. The platform focuses on the visualization of cancer indicators to illustrate the changing scale, epidemiological profile, and impact of the disease worldwide, using data from several key projects of IARC’s Section of Cancer

  • Nature Reviews Cancer Impact Factor Abbreviation ISSN

     · Year. Impact Factor (IF) 2016/2017. 37.147. 2015. 34.244. 2014. 37.400. 2013.

  • Cancer LettersJournalElsevier

    Cancer Letters is a part of Elsevier’s Oncology Journal Network. As part of Article Advance, Cancer Letters ensures a fast, seamless publication process and offers additional support from a dedicated editorial team. With Cancer Letters indexed in Pubmed/Medline, your published article is guaranteed maximum visibility.

  • Cancer Cells vs. Normal Cells How Are They Different?

     · Cancer cells, in contrast, don’t respect boundaries and invade tissues. This results in the fingerlike projections that are often noted on radiologic scans of cancerous tumors. The word cancer, in fact, comes from the Latin word for crab used to describe the

  • Exosomes in the tumor microenvironment Molecular Cancer

     · Exosomes are small extracellular vesicles that contain genetic material, proteins, and lipids. They function as potent signaling molecules between cancer cells and the surrounding cells that comprise the tumor microenvironment (TME). Exosomes derived from both tumor and stromal cells have been implicated in all stages of cancer progression and play an important role in therapy resistance.

  • Journal Impact Factor ListScopusJournals

     · Journal Impact Factor List 2020. ID Print-ISSN J. I. Factor Full Journal Title. .278CA-A CANCER JOURNAL FOR CLINICIANS. .699NEW ENGLAND JOURNAL OF MEDICINE. .189Nature Reviews Materials. .797NATURE REVIEWS DRUG DISCOVERY.

  • Biochimica et Biophysica ActaReviews on Cancer

    BBA Reviews on Cancer covers the whole field of the biology and biochemistry of cancer, emphasizing oncogenes and tumor suppressor genes, growth-related cell cycle control signalling, carcinogenesis mechanisms, cell transformation, immunologic control mechanisms, genetics of human (mammalian) cancer, control of cell proliferation, genetic and molecular control of organismic development

  • Natural Product Reports Home-High impact, critical reviews

    Natural Product Reports Impact factor 13.423 Issues per year 12 High impact, critical reviews in natural products research and related areas . Submit your article Opens in new window Information and templates for authors

  • One year of Nature Cancer Nature Cancer

     · In cancer genomics, primary research included studies on the impact of cancer genomes, epigenomes and gene-expression programs on tumor development, progression and response to

  • Nature Reviews Materials Journal Impact IF

    Journal Impact IF Ranking. · In the Biomaterials research field, the Quartile of Nature Reviews Materials is Q1. Nature Reviews Materials has been ranked #1 over 100 related journals in the Biomaterials research category. The ranking percentile of Nature Reviews Materials is

  • Cancer Communications, , Chinese

     · Cancer Communications PubMed Indexed SCI Indexed Impact Factor 10.392 Submission Website Cancer Communications 202010.392 Cancer Communications 2020 Wiley 《》 Cancer Communications

  • Journal Impact Factor ListScopusJournals

     · Impact Factor Calculations IF 2018 = (Citation in 2017 Citations in 2016)/(Papers Published in 2017 Papers Published in 2016) Journal Impact Factor List 2020 ID Print-ISSN J. I. Factor Full Journal Title .278CA-A CANCER JOURNAL FOR CLINICIANS .699NEW ENGLAND JOURNAL OF MEDICINE

  • High Impact Journals (Superfund Research Program)

    Superfund Research Program. Many SRP scientists have published their findings in "high-impact journals"those considered to be highly influential in their fields. A journal's impact factor is a measure of the frequency with which an average article in a journal has been cited in a particular year.

  • Nature Reviews Cancer Journal Impact IF

    Nature Reviews Cancer Key Factor Analysis. · The Journal Impact IF of Nature Reviews Cancer is 37.912. Nature Reviews Cancer Key Factor Analysis. · The Journal Impact IF of Nature Reviews Cancer is 35.0. Nature Reviews Cancer Key Factor

  • Nature Reviews Cancer Impact Factor Abbreviation ISSN

     · Nature Reviews Cancer. Abbreviation Nat Rev Cancer. ISSN X (Print) (Electronic) X (Linking)

  • Home Page Cancer Treatment Reviews

     · Cancer Treatment Reviews (Incorporating Evidence-based Oncology) is an international review journal that will keep both the clinician and researcher abreast of modern concepts and developments in cancer treatment research through the publication of state of the art, authoritative reviews evidence-based reviews (using a priori defined selection

  • Computational modeling of ovarian cancer dynamics

     · The optimal timing of surgery/chemotherapy and the benefits of earlier diagnosis of HGSC remain controversial. We developed a mathematical framework of tumor dynamics, populated the model with primary clinical data, and reliably recapitulated clinical observations. Our model predicts that 1) PDS is superior to NACT with relatively small tumor burden and when complete debulking is feasible, 2

  • Home Page Cancer Treatment Reviews

     · 2019 Impact Factor 8.885 View More on Journal Insights © 2019 Journal Citation Report ® Clarivate Analytics, 2020

  • Addgene Ras Pathway

    Return to top Resources. RAS Pathway Clone Collection 2.0 Set of vectors from the Esposito Lab for use with the Gateway® Cloning Platform (Life Technologies™) to permit construction of RAS pathway gene expression vectors for in vitro and in vivo research. The RAS Initiative- at the National Cancer Institute (NCI). References. Ras oncogenes and their downstream targets.

  • Home Cancer Research

     · Home Cancer Research. The AACR remains fully committed to supporting publishing operations throughout this challenging time, while still remaining flexible and supportive of the author, reviewer, and editor communities that we serve. If you have any questions or concerns, please reach out to a member of the AACR publishing staff.

  • Tumour necrosis factor and cancerPubMed

    Tumour necrosis factor (TNF) is a major inflammatory cytokine that was first identified for its ability to induce rapid haemorrhagic necrosis of experimental cancers. When efforts to harness this anti-tumour activity in cancer treatments were underway, a paradoxical tumour